T1	PROC 46 60	Ensayo clínico
#1	AnnotatorNotes T1	C0008976; Clinical Trials; Research Activity
T2	PROC 91 116	control de la temperatura
#2	AnnotatorNotes T2	C0412806; Thermoregulation measures; Therapeutic or Preventive Procedure
T3	DISO 134 147	shock séptico
#3	AnnotatorNotes T3	C0036983; Septic Shock; Pathologic Function
T4	PROC 251 276	control de la temperatura
#4	AnnotatorNotes T4	C0412806; Thermoregulation measures; Therapeutic or Preventive Procedure
T5	DISO 294 307	shock séptico
#5	AnnotatorNotes T5	C0036983; Septic Shock; Pathologic Function
T6	DISO 332 345	shock séptico
#6	AnnotatorNotes T6	C0036983; Septic Shock; Pathologic Function
T7	PROC 407 422	ingresen en UCI
#7	AnnotatorNotes T7	C0583239; Admission to intensive care unit; Health Care Activity
T8	PROC 427 438	diagnóstico
#8	AnnotatorNotes T8	C0011900; Diagnosis; Diagnostic Procedure
T9	DISO 442 455	shock séptico
#9	AnnotatorNotes T9	C0036983; Septic Shock; Pathologic Function
T10	PROC 589 600	diagnóstico
#10	AnnotatorNotes T10	C0011900; Diagnosis; Diagnostic Procedure
T11	DISO 604 617	shock séptico
#11	AnnotatorNotes T11	C0036983; Septic Shock; Pathologic Function
T12	DISO 901 909	sangrado
#12	AnnotatorNotes T12	C0019080; Hemorrhage; Pathologic Function
T13	DISO 918 930	coagulopatía
#13	AnnotatorNotes T13	C0005779; Blood Coagulation Disorders; Disease or Syndrome
T14	PROC 942 955	cirugía mayor
#14	AnnotatorNotes T14	C0679637; major surgery; Therapeutic or Preventive Procedure
T15	DISO 982 1001	enfermedad terminal
T16	DISO 1046 1058	gran quemado
T17	PROC 1071 1084	cirugía mayor
#15	AnnotatorNotes T17	C0679637; major surgery; Therapeutic or Preventive Procedure
T18	DISO 1198 1214	inmunodeprimidos
#16	AnnotatorNotes T18	C0085393; Immunocompromised Host; Finding
T19	PROC 1236 1263	tratamiento con corticoides
T20	PROC 1265 1280	inmunosupresión
#17	AnnotatorNotes T20	C0021079; Therapeutic immunosuppression; Therapeutic or Preventive Procedure
T21	PROC 1286 1296	trasplante
#18	AnnotatorNotes T21	C0040732; Transplantation; Therapeutic or Preventive Procedure
T22	DISO 1314 1331	inmunodeficiencia
#19	AnnotatorNotes T22	C0021051; Immunologic Deficiency Syndromes; Disease or Syndrome
T23	DISO 1354 1363	alérgicos
#20	AnnotatorNotes T23	C1527304; Allergic Reaction; Pathologic Function
T24	CHEM 1366 1377	Paracetamol
#21	AnnotatorNotes T24	C0000970; acetaminophen; Organic Chemical · Pharmacologic Substance
T25	CHEM 1382 1391	Metamizol
#22	AnnotatorNotes T25	C0012586; dipyrone; Organic Chemical · Pharmacologic Substance | C3714569; metamizole sodium; Organic Chemical · Pharmacologic Substance
T26	PROC 1565 1579	ensayo clínico
#23	AnnotatorNotes T26	C0008976; Clinical Trials; Research Activity
T27	PROC 171 220	Ensayo clínico controlado aleatorizado en fase IV
T28	PROC 698 722	consentimiento informado
#24	AnnotatorNotes T28	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T29	CHEM 1252 1263	corticoides
#25	AnnotatorNotes T29	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T30	PROC 1420 1444	consentimiento informado
#26	AnnotatorNotes T30	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T31	PROC 1132 1157	colocación de los parches
T32	Date 13 17	2016
T33	LIVB 120 129	pacientes
#27	AnnotatorNotes T33	C0030705; Patients; Patient or Disabled Group
T34	LIVB 280 289	pacientes
#28	AnnotatorNotes T34	C0030705; Patients; Patient or Disabled Group
T35	LIVB 374 383	Pacientes
#29	AnnotatorNotes T35	C0030705; Patients; Patient or Disabled Group
T36	Age 384 402	mayores de 18 años
T38	Duration 559 580	las primeras 12 horas
T40	Duration 670 684	>= de 48 horas
T41	LIVB 737 745	paciente
#30	AnnotatorNotes T41	C0030705; Patients; Patient or Disabled Group
T42	LIVB 748 758	familiares
#31	AnnotatorNotes T42	C0080103; Relative (related person); Family Group
T43	LIVB 787 796	Pacientes
#32	AnnotatorNotes T43	C0030705; Patients; Patient or Disabled Group
T44	Age 797 815	menores de 18 años
T45	LIVB 819 828	Pacientes
#33	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group
T46	Spec_cue 868 877	supuestos
T47	PHYS 879 887	embarazo
#34	AnnotatorNotes T47	C0032961; Pregnancy; Organism Function
T48	PHYS 890 899	lactancia
#35	AnnotatorNotes T48	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T49	Duration 959 979	las 24 horas previas
T50	Duration 1023 1032	< 6 meses
T51	LIVB 1037 1045	Paciente
#36	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T53	Neg_cue 1122 1128	impida
T54	Form 1150 1157	parches
#37	AnnotatorNotes T54	C4722398; Patch Dosage Form; Biomedical or Dental Material
T55	LIVB 1344 1353	Pacientes
#38	AnnotatorNotes T55	C0030705; Patients; Patient or Disabled Group
T56	Neg_cue 1395 1406	Ausencia de
T57	LIVB 1459 1467	paciente
#39	AnnotatorNotes T57	C0030705; Patients; Patient or Disabled Group
T58	LIVB 1470 1480	familiares
#40	AnnotatorNotes T58	C0080103; Relative (related person); Family Group
T60	LIVB 1530 1538	paciente
#41	AnnotatorNotes T60	C0030705; Patients; Patient or Disabled Group
T61	LIVB 1613 1625	investigador
#42	AnnotatorNotes T61	C0035173; Research Personnel; Professional or Occupational Group
T64	LIVB 1188 1197	Pacientes
#43	AnnotatorNotes T64	C0030705; Patients; Patient or Disabled Group
T52	Spec_cue 1109 1117	supuesto
T37	PROC 654 669	estancia en UCI
#44	AnnotatorNotes T37	C5419131; Intensive Care Unit Stay; Health Care Activity
A1	Assertion T30 Negated
A2	Assertion T31 Negated
A3	Assertion T47 Speculated
A4	Assertion T48 Speculated
A5	Assertion T12 Speculated
A6	Assertion T13 Speculated
A7	Assertion T14 Speculated
A8	Assertion T15 Speculated
A9	Assertion T17 Speculated
A10	Assertion T16 Speculated
A11	Status T14 History_of
A12	Status T22 History_of
A13	Status T23 History_of
#45	AnnotatorNotes T27	C0206035; Controlled Clinical Trials, Randomized; Research Activity + C0282462; Phase 4 Clinical Trials; Research Activity 
#46	AnnotatorNotes T15	C0679247; Terminal illness; Disease or Syndrome
R1	Speculation Arg1:T52 Arg2:T17	
R2	Speculation Arg1:T52 Arg2:T16	
R3	Negation Arg1:T53 Arg2:T31	
T39	Neg_cue 1483 1493	negativa a
T59	Observation 1494 1518	participar en el estudio
A14	Assertion T59 Negated
#47	AnnotatorNotes T59	C1278516; Patient participation status; Finding
R4	Negation Arg1:T39 Arg2:T59	
R5	Negation Arg1:T56 Arg2:T30	
T62	CONC 532 541	inclusión
#48	AnnotatorNotes T62	C1512693; Inclusion; Qualitative Concept
R6	Overlap Arg1:T62 Arg2:T38	
R7	After Arg1:T62 Arg2:T10	
R8	After Arg1:T62 Arg2:T11	
T63	Observation 78 84	efecto
#49	AnnotatorNotes T63	C1518681; Outcome of Therapy; Finding (?)
R9	Experiences Arg1:T33 Arg2:T63	
R10	Experiences Arg1:T33 Arg2:T2	
R11	Experiences Arg1:T33 Arg2:T3	
T65	Observation 238 244	efecto
#50	AnnotatorNotes T65	C1518681; Outcome of Therapy; Finding (?)
R12	Experiences Arg1:T34 Arg2:T65	
R15	Experiences Arg1:T34 Arg2:T5	
R16	Experiences Arg1:T34 Arg2:T4	
R17	Has_Age Arg1:T35 Arg2:T36	
R18	Experiences Arg1:T35 Arg2:T7	
R19	Experiences Arg1:T35 Arg2:T9	
T66	CONC 488 496	estancia
#51	AnnotatorNotes T66	C3489408; Hospital Stay; Temporal Concept | C0420512; Inpatient stay; Functional Concept
R20	Overlap Arg1:T9 Arg2:T66	
R21	Has_Duration_or_Interval Arg1:T37 Arg2:T40	
T67	CONC 635 648	supervivencia
#52	AnnotatorNotes T67	C0220921; survival aspects; Functional Concept
R22	Has_Age Arg1:T43 Arg2:T44	
R23	Experiences Arg1:T45 Arg2:T47	
R24	Experiences Arg1:T45 Arg2:T48	
R25	Experiences Arg1:T45 Arg2:T12	
R26	Speculation Arg1:T46 Arg2:T47	
R27	Speculation Arg1:T46 Arg2:T48	
R28	Speculation Arg1:T46 Arg2:T12	
R29	Speculation Arg1:T46 Arg2:T13	
R30	Speculation Arg1:T46 Arg2:T14	
R31	Overlap Arg1:T14 Arg2:T49	
R32	Speculation Arg1:T46 Arg2:T15	
T68	CONC 1003 1022	expectativa de vida
#53	AnnotatorNotes T68	C0023671; Life Expectancy; Group Attribute
R33	Has_Duration_or_Interval Arg1:T68 Arg2:T50	
T69	Quantifier_or_Qualifier 910 916	activo
A15	Assertion T69 Speculated
#54	AnnotatorNotes T69	C0679217; Active State; Idea or Concept
R34	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T69	
R35	Speculation Arg1:T46 Arg2:T69	
T70	Quantifier_or_Qualifier 931 940	congénita
#55	AnnotatorNotes T70	C1744681; Congenital qualifier; Qualitative Concept
R36	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T70	
A16	Assertion T70 Speculated
R37	Speculation Arg1:T46 Arg2:T70	
R38	Experiences Arg1:T45 Arg2:T13	
R39	Experiences Arg1:T45 Arg2:T14	
R40	Experiences Arg1:T45 Arg2:T15	
R41	Experiences Arg1:T51 Arg2:T16	
R42	Experiences Arg1:T51 Arg2:T17	
R43	Has_Drug_Form Arg1:T31 Arg2:T54	
R44	Experiences Arg1:T51 Arg2:T31	
R46	Before Arg1:T17 Arg2:T31	
R47	Experiences Arg1:T64 Arg2:T18	
R48	Used_for Arg1:T29 Arg2:T19	
R49	Causes Arg1:T19 Arg2:T18	
R50	Causes Arg1:T20 Arg2:T18	
R51	After Arg1:T20 Arg2:T21	
R52	Experiences Arg1:T64 Arg2:T19	
R53	Experiences Arg1:T64 Arg2:T20	
R54	Experiences Arg1:T64 Arg2:T21	
R55	Experiences Arg1:T64 Arg2:T22	
R56	Causes Arg1:T24 Arg2:T23	
R57	Causes Arg1:T25 Arg2:T23	
R58	Experiences Arg1:T55 Arg2:T23	
T71	Observation 1544 1579	participando en otro ensayo clínico
R61	Has_Duration_or_Interval Arg1:T11 Arg2:T38	
R13	Causes Arg1:T22 Arg2:T18	
#56	AnnotatorNotes T19	C0149783; Steroid therapy; Therapeutic or Preventive Procedure
A17	Experiencer T33 Patient
A18	Experiencer T34 Patient
A19	Experiencer T35 Patient
A20	Status T9 Future
A21	Status T67 Future
A22	Status T37 Future
A23	Status T40 Future
A24	Experiencer T41 Patient
A25	Experiencer T42 Family_member
A26	Experiencer T43 Patient
A27	Experiencer T45 Patient
A28	Experiencer T51 Patient
A29	Experiencer T64 Patient
A30	Experiencer T55 Patient
A31	Experiencer T57 Patient
A32	Experiencer T58 Family_member
A33	Experiencer T60 Patient
A34	Experiencer T61 Other
